The Procurement of a Biomark X9 Microfluidics System

The Food and Drug Administration is forecasting the future procurement of a Biomark X9 Microfluidics System under NAICS code 423450, which pertains to medical and surgical equipment and supplies merchant wholesalers. The opportunity was posted on May 25, 2026, and is currently in the forecast stage, indicating preliminary intent rather than an active solicitation. The system is intended for use by the agency likely in research or analytical capacities related to biological and pharmaceutical evaluation. The point of contact for program inquiries is the CBER Acquisition Liaison, reachable at cberacquisitions@fda.hhs.gov, while the contracting officer position is still to be determined. The place of performance and specific location details have not been specified, and there is no set-aside designation indicated for small businesses or other categories. No solicitation number has been assigned yet, and interested parties should monitor the official HHS OSDBU portal for updates on the upcoming formal solicitation.